Bruker Corp (BRKR)
56.54
+0.32
(+0.57%)
USD |
NASDAQ |
Nov 22, 13:10
Bruker Total Assets (Quarterly): 6.113B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.113B |
| June 30, 2024 | 5.903B |
| March 31, 2024 | 4.506B |
| December 31, 2023 | 4.250B |
| September 30, 2023 | 3.820B |
| June 30, 2023 | 3.857B |
| March 31, 2023 | 3.764B |
| December 31, 2022 | 3.612B |
| September 30, 2022 | 3.337B |
| June 30, 2022 | 3.385B |
| March 31, 2022 | 3.551B |
| December 31, 2021 | 3.65B |
| September 30, 2021 | 3.128B |
| June 30, 2021 | 3.087B |
| March 31, 2021 | 3.035B |
| December 31, 2020 | 3.049B |
| September 30, 2020 | 2.879B |
| June 30, 2020 | 2.943B |
| March 31, 2020 | 2.962B |
| December 31, 2019 | 2.772B |
| September 30, 2019 | 2.352B |
| June 30, 2019 | 2.350B |
| March 31, 2019 | 2.242B |
| December 31, 2018 | 2.129B |
| September 30, 2018 | 1.889B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.806B |
| March 31, 2018 | 1.830B |
| December 31, 2017 | 1.948B |
| September 30, 2017 | 1.962B |
| June 30, 2017 | 1.913B |
| March 31, 2017 | 1.840B |
| December 31, 2016 | 1.808B |
| September 30, 2016 | 1.798B |
| June 30, 2016 | 1.720B |
| March 31, 2016 | 1.740B |
| December 31, 2015 | 1.73B |
| September 30, 2015 | 1.843B |
| June 30, 2015 | 1.820B |
| March 31, 2015 | 1.773B |
| December 31, 2014 | 1.865B |
| September 30, 2014 | 1.911B |
| June 30, 2014 | 2.004B |
| March 31, 2014 | 2.028B |
| December 31, 2013 | 1.988B |
| September 30, 2013 | 1.936B |
| June 30, 2013 | 1.802B |
| March 31, 2013 | 1.812B |
| December 31, 2012 | 1.856B |
| September 30, 2012 | 1.80B |
| June 30, 2012 | 1.750B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.772B
Minimum
Dec 2019
6.113B
Maximum
Sep 2024
3.680B
Average
3.468B
Median
Total Assets (Quarterly) Benchmarks
| Azenta Inc | 2.100B |
| Harvard Bioscience Inc | 131.24M |
| Bionano Genomics Inc | 87.36M |
| Akoya Biosciences Inc | 129.97M |
| Singular Genomics Systems Inc | 186.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.270B |
| Shareholders Equity (Quarterly) | 1.807B |
| Debt to Equity Ratio | 1.271 |
| Current Ratio | 1.658 |
| Net Debt Paydown Yield | -2.01% |